AU9095998A - Remedies for dysuria resulting from prostatic hypertrophy - Google Patents

Remedies for dysuria resulting from prostatic hypertrophy

Info

Publication number
AU9095998A
AU9095998A AU90959/98A AU9095998A AU9095998A AU 9095998 A AU9095998 A AU 9095998A AU 90959/98 A AU90959/98 A AU 90959/98A AU 9095998 A AU9095998 A AU 9095998A AU 9095998 A AU9095998 A AU 9095998A
Authority
AU
Australia
Prior art keywords
dysuria
remedies
resulting
prostatic hypertrophy
prostatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU90959/98A
Inventor
Katsuyoshi Akiyama
Masami Kojima
Ikunobu Muramatsu
Satoshi Murata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kissei Pharmaceutical Co Ltd
Original Assignee
Kissei Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Co Ltd filed Critical Kissei Pharmaceutical Co Ltd
Publication of AU9095998A publication Critical patent/AU9095998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
AU90959/98A 1997-09-22 1998-09-21 Remedies for dysuria resulting from prostatic hypertrophy Abandoned AU9095998A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP29613597 1997-09-22
JP9-296135 1997-09-22
PCT/JP1998/004234 WO1999015202A1 (en) 1997-09-22 1998-09-21 Remedies for dysuria resulting from prostatic hypertrophy

Publications (1)

Publication Number Publication Date
AU9095998A true AU9095998A (en) 1999-04-12

Family

ID=17829612

Family Applications (1)

Application Number Title Priority Date Filing Date
AU90959/98A Abandoned AU9095998A (en) 1997-09-22 1998-09-21 Remedies for dysuria resulting from prostatic hypertrophy

Country Status (2)

Country Link
AU (1) AU9095998A (en)
WO (1) WO1999015202A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL342477A1 (en) * 1998-02-27 2001-06-04 Kissei Pharmaceutical Derivatives of indole and pharmacological compositions containing them
US6730065B1 (en) 2000-09-15 2004-05-04 Ocularis Pharma, Inc. Night vision composition
US8889112B2 (en) 1999-09-16 2014-11-18 Ocularis Pharma, Llc Ophthalmic formulations including selective alpha 1 antagonists
UA78854C2 (en) * 2002-09-06 2007-04-25 Kissei Pharmaceutical Crystal for an oral solid drug and oral solid drug for dysuria treatment containing the same
JP4805234B2 (en) * 2002-12-16 2011-11-02 キッセイ薬品工業株式会社 Oral solid medicine
MXPA05006513A (en) * 2002-12-16 2005-09-08 Kissei Pharmaceutical Solid drug for oral use.
EP1724257B1 (en) 2004-03-05 2013-11-13 Kissei Pharmaceutical Co., Ltd. Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder
EP1800677A4 (en) * 2004-10-05 2008-04-02 Kissei Pharmaceutical Preventive and/or therapeutic agent for urine collection disorder accompanying lower urinary tract obstruction
SI1806136T1 (en) * 2004-10-06 2012-03-30 Kissei Pharmaceutical Medicinal composition for prevention of transition to operative treatment for prostatic hypertrophy
CN104211631A (en) * 2013-05-30 2014-12-17 中国科学院上海药物研究所 Indoles compound, preparation method thereof, pharmaceutical composition and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69319551T2 (en) * 1992-12-02 1998-10-29 Kissei Pharmaceutical Indoline compounds used to treat dysurias
JP3331048B2 (en) * 1994-06-01 2002-10-07 キッセイ薬品工業株式会社 Indole derivatives

Also Published As

Publication number Publication date
WO1999015202A1 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
AU2355497A (en) Optimising an expression tree for the production of images
AU4525799A (en) Requirements matching
AU1718397A (en) Micromixer
AU5276398A (en) Wavelength manager
AU6928698A (en) Service creation
AU4106897A (en) Coupling
AU3755899A (en) Computer architecture using self-manipulating trees
AU9066598A (en) Substituted 4-benzoyl-pyrazoles
AU7476598A (en) 18-substituted-19-nor-vitamin d compounds
AU9095998A (en) Remedies for dysuria resulting from prostatic hypertrophy
AU1998399A (en) Computer instruction which generates multiple data-type results
AU2701799A (en) Computers
AU6134099A (en) Service creation environment
AU3942697A (en) Hinged case
AU1753599A (en) Benzenesulfonamide compounds
AU6090898A (en) Substituted 4-benzoyl-pyrazoles
AUPP003297A0 (en) 4,5-diaryloxazole compounds
AU1110699A (en) Estra-1,3,5(10)-triene-7alpha-thioethers
AU8824398A (en) Computer
AU4092497A (en) Modified lignins
AU3073695A (en) Coater startup
AU7530198A (en) Substituted 4-benzoyl-pyrazoles
AU7212698A (en) Substituted aryluracils
AU2908297A (en) Herbicidal indolines
AU9099798A (en) Diffusor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase